Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

Discover how PEARL, a cfDNA-based method, enhances early preeclampsia detection, offering safer, non-invasive prenatal ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Scientists have developed a breakthrough method to track diet using stool metagenomic data. This non-invasive, data-driven approach offers an objective alternative to traditional food diaries and ...

A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

Researchers from The University of Manchester—in collaboration with the Universities of Granada, Lund, and Oslo—have ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...

Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly.

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...

Due to its proximity to humans, it regularly, although involuntarily hitches a ride on ships and planes, eventually invading ...